UK Stocks-Factors to watch on Feb 23

Feb 23 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.22%.

* ASTRAZENECA: A large study into rare blood clots linked with AstraZeneca's AZN.L COVID-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot.

* RUSSIA-UKRAINE: The European Union agreed new sanctions on Russia that will blacklist more politicians, lawmakers and officials, ban EU investors from trading in Russian state bonds, and target imports and exports with separatist entities.

* NATIONAL GRID: Britain's auction to ensure enough electricity capacity for 2025/26 has cleared at a 30.59 pounds ($41.54) per kilowatt (kW) per year range, National Grid said.

* METALS: Nickel and aluminium held near multi-year highs, as investors weighed the tense developments in eastern Europe that has ignited worries over the possibility of sanctions on Russia, a major producer of the metals.

* GOLD: Gold was flat, holding near a nine-month high hit in the last session, as safe-haven demand was offset by a rise in Treasury yields following the first wave of U.S. and European sanctions on Russia for sending troops into eastern Ukraine.

* OIL: Oil prices took a breather after surging to seven-year highs in the previous session as it became clear the first wave of U.S. and European sanctions on Russia for sending troops into eastern Ukraine would not disrupt oil supply.

* London's FTSE 100 stock index closed higher on Tuesday, recouping earlier losses as strong results from medical products maker Smith+Nephew and gains in industrial stocks countered concerns relating to the Russia-Ukraine crisis.


Capital & Counties


FY results Hochschild


FY results Metro Bank


FY results Unite Group


FY results Barclays


FY results Ted Baker


Trading update Rio Tinto


FY results

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Amna Karimi in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.